drugset / Trial / NCT03966560
Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Glaucoma is one of the leading causes of blindness worldwide that is a chronic public health problem. Unfortunately, glaucoma can be diagnosed when the disease reaches a certain level in today's conditions. The aim of this study was to investigate the diagnostic methods that can diagnose glaucoma before it reaches the advanced level and to identify pathophysiological processes. In this study, choroidal thickness was investigated in primary open-angle glaucoma cases and its correlations with OCT and multifocal ERG parameters were evaluated.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-01
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.03 % | Topical |
| Subject | Brimonidine | Small molecule | 0.15 % | Topical |
| Subject | Brinzolamide | Small molecule | 10 mg/ml | Topical |
| Subject | Dorzolamide | Small molecule | 20 mg/ml | Topical |
| Subject | Latanoprost | Small molecule | 0.005 % | Topical |
| Subject | Timolol | Other / unclassified | 0.5 % | Topical |
| Subject | Timolol | Other / unclassified | 5 mg/ml | Topical |
| Subject | Travoprost | Other / unclassified | 0.004 % | Topical |